Search research articles
Contact Us
Filters
Showing results (71-80 of 328) with videos related to
Page
of 33
Sort By:
Virology
|
August 1, 1980
In animals infected by bovine leukemia virus (BLV) antibodies to envelope glycoprotein gp51 are directed against the carbohydrate moiety
D Portetelle, C Bruck, M Mammerickx, et al.
Virology
|
June 1, 1995
Mutations in the p53 tumor-suppressor gene are frequently associated with bovine leukemia virus-induced leukemogenesis in cattle but not in sheep
F Dequiedt, R Kettmann, A Burny, et al.
Oncogene
|
June 1, 1995
Wild-type p53 down-regulates transcription from oncogenic human papillomavirus promoters through the epithelial specific enhancer
C Desaintes, S Hallez, O Detremmerie, et al.
Virus Genes
|
January 1, 1994
Expression of biologically active envelope glycoprotein from the acutely pathogenic simian immunodeficiency virus SIVsmmPBj
S A González, J L Affranchino, A Burny
Journal of Virology
|
June 1, 1985
Role of the 3' long open reading frame region of bovine leukemia virus in the maintenance of cell transformation
R Kettmann, Y Cleuter, D Gregoire, et al.
The EMBO Journal
|
July 1, 1996
The solution structure of the bovine leukaemia virus matrix protein and similarity with lentiviral matrix proteins
S Matthews, M Mikhailov, A Burny, et al.
Journal of Virology
|
January 1, 1992
Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16
C Desaintes, S Hallez, P Van Alphen, et al.
European Journal of Biochemistry
|
June 1, 1994
Identification of functional sites on bovine leukemia virus envelope glycoproteins using structural and immunological data
I Callebaut, D Portetelle, A Burny, et al.
Transactions of the American Neurological Association
|
January 1, 1971
Visna virus: a "slow" neurotropic agent with tumor virus properties
D H Harter, J Schlom, A Burny, et al.
Leukemia
|
April 1, 1994
The bovine leukemia virus (BLV) envelope glycoprotein gp51 as a general model for the design of a subunit vaccine against retroviral infection: mapping of functional sites through immunological and structural data
I Callebaut, J P Mornon, A Burny, et al.
Page
of 33
Search research articles
Search
Showing results (71-80 of 328) with videos related to
Sort By:
Page
of 33
Virology
|
August 1, 1980
In animals infected by bovine leukemia virus (BLV) antibodies to envelope glycoprotein gp51 are directed against the carbohydrate moiety
D Portetelle, C Bruck, M Mammerickx, et al.
Virology
|
June 1, 1995
Mutations in the p53 tumor-suppressor gene are frequently associated with bovine leukemia virus-induced leukemogenesis in cattle but not in sheep
F Dequiedt, R Kettmann, A Burny, et al.
Oncogene
|
June 1, 1995
Wild-type p53 down-regulates transcription from oncogenic human papillomavirus promoters through the epithelial specific enhancer
C Desaintes, S Hallez, O Detremmerie, et al.
Virus Genes
|
January 1, 1994
Expression of biologically active envelope glycoprotein from the acutely pathogenic simian immunodeficiency virus SIVsmmPBj
S A González, J L Affranchino, A Burny
Journal of Virology
|
June 1, 1985
Role of the 3' long open reading frame region of bovine leukemia virus in the maintenance of cell transformation
R Kettmann, Y Cleuter, D Gregoire, et al.
The EMBO Journal
|
July 1, 1996
The solution structure of the bovine leukaemia virus matrix protein and similarity with lentiviral matrix proteins
S Matthews, M Mikhailov, A Burny, et al.
Journal of Virology
|
January 1, 1992
Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16
C Desaintes, S Hallez, P Van Alphen, et al.
European Journal of Biochemistry
|
June 1, 1994
Identification of functional sites on bovine leukemia virus envelope glycoproteins using structural and immunological data
I Callebaut, D Portetelle, A Burny, et al.
Transactions of the American Neurological Association
|
January 1, 1971
Visna virus: a "slow" neurotropic agent with tumor virus properties
D H Harter, J Schlom, A Burny, et al.
Leukemia
|
April 1, 1994
The bovine leukemia virus (BLV) envelope glycoprotein gp51 as a general model for the design of a subunit vaccine against retroviral infection: mapping of functional sites through immunological and structural data
I Callebaut, J P Mornon, A Burny, et al.
Page
of 33